148 related articles for article (PubMed ID: 10410494)
1. Comparison of the efficacy and acceptability of atypical antipsychotic drugs: a meta-analysis of randomized, placebo-controlled trials.
Srisurapanont M; Maneeton N
J Med Assoc Thai; 1999 Apr; 82(4):341-6. PubMed ID: 10410494
[TBL] [Abstract][Full Text] [Related]
2. Meta-analysis comparing newer antipsychotic drugs for the treatment of schizophrenia: evaluating the indirect approach.
Sauriol L; Laporta M; Edwardes MD; Deslandes M; Ricard N; Suissa S
Clin Ther; 2001 Jun; 23(6):942-56. PubMed ID: 11440294
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials.
Leucht S; Pitschel-Walz G; Abraham D; Kissling W
Schizophr Res; 1999 Jan; 35(1):51-68. PubMed ID: 9988841
[TBL] [Abstract][Full Text] [Related]
4. Differential rates of treatment discontinuation in clinical trials as a measure of treatment effectiveness for olanzapine and comparator atypical antipsychotics for schizophrenia.
Kinon BJ; Liu-Seifert H; Adams DH; Citrome L
J Clin Psychopharmacol; 2006 Dec; 26(6):632-7. PubMed ID: 17110821
[TBL] [Abstract][Full Text] [Related]
5. [Atypical antipsychotics].
Naber D
Nervenarzt; 2000 May; 71(5):327-8. PubMed ID: 10846707
[No Abstract] [Full Text] [Related]
6. Selecting an atypical antipsychotic by combining clinical experience with guidelines from clinical trials.
Stahl SM
J Clin Psychiatry; 1999; 60 Suppl 10():31-41. PubMed ID: 10340685
[TBL] [Abstract][Full Text] [Related]
7. Schizophrenia, VI: Treatments.
Lieberman JA; Stroup TS
Am J Psychiatry; 2003 Oct; 160(10):1748. PubMed ID: 14514482
[No Abstract] [Full Text] [Related]
8. Risk of discontinuation of atypical antipsychotic agents in the treatment of schizophrenia.
Mullins CD; Obeidat NA; Cuffel BJ; Naradzay J; Loebel AD
Schizophr Res; 2008 Jan; 98(1-3):8-15. PubMed ID: 17596914
[TBL] [Abstract][Full Text] [Related]
9. Cost effectiveness of the newer atypical antipsychotics: a review of the pharmacoeconomic research evidence.
Revicki DA
Curr Opin Investig Drugs; 2001 Jan; 2(1):110-7. PubMed ID: 11527002
[TBL] [Abstract][Full Text] [Related]
10. Consistency of atypical antipsychotic superiority to placebo in recent clinical trials.
Woods SW; Stolar M; Sernyak MJ; Charney DS
Biol Psychiatry; 2001 Jan; 49(1):64-70. PubMed ID: 11163781
[TBL] [Abstract][Full Text] [Related]
11. [Atypical antipsychotic drugs].
Kahn RS
Ned Tijdschr Geneeskd; 2000 Aug; 144(34):1627-30. PubMed ID: 10972052
[TBL] [Abstract][Full Text] [Related]
12. Clinical trial response and dropout rates with olanzapine versus risperidone.
Santarlasci B; Messori A
Ann Pharmacother; 2003 Apr; 37(4):556-63. PubMed ID: 12659615
[TBL] [Abstract][Full Text] [Related]
13. Two new atypical antipsychotics: advantages and disadvantages.
Lemon MD
S D J Med; 1998 Aug; 51(8):285-6. PubMed ID: 9724957
[No Abstract] [Full Text] [Related]
14. A double-blind comparison of risperidone, quetiapine and placebo in patients with schizophrenia experiencing an acute exacerbation requiring hospitalization.
Potkin SG; Gharabawi GM; Greenspan AJ; Mahmoud R; Kosik-Gonzalez C; Rupnow MF; Bossie CA; Davidson M; Burtea V; Zhu Y; Trivedi JK
Schizophr Res; 2006 Jul; 85(1-3):254-65. PubMed ID: 16797162
[TBL] [Abstract][Full Text] [Related]
15. Dropout rates in placebo-controlled and active-control clinical trials of antipsychotic drugs: a meta-analysis.
Kemmler G; Hummer M; Widschwendter C; Fleischhacker WW
Arch Gen Psychiatry; 2005 Dec; 62(12):1305-12. PubMed ID: 16330718
[TBL] [Abstract][Full Text] [Related]
16. Comparison of three antipsychotics in the emergency psychiatric setting.
Raja M; Azzoni A
Hum Psychopharmacol; 2003 Aug; 18(6):447-52. PubMed ID: 12923822
[TBL] [Abstract][Full Text] [Related]
17. Measuring outcome in schizophrenia: differences among the atypical antipsychotics. Collaborative Working Group on Clinical Trial Evaluations.
J Clin Psychiatry; 1998; 59 Suppl 12():3-9. PubMed ID: 9766613
[TBL] [Abstract][Full Text] [Related]
18. Clozapine: a comparison with other novel antipsychotics.
Fleischhacker WW
J Clin Psychiatry; 1999; 60 Suppl 12():30-4. PubMed ID: 10372608
[TBL] [Abstract][Full Text] [Related]
19. Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis.
Geddes J; Freemantle N; Harrison P; Bebbington P
BMJ; 2000 Dec; 321(7273):1371-6. PubMed ID: 11099280
[TBL] [Abstract][Full Text] [Related]
20. Ziprasidone: a new atypical antipsychotic.
Keck PE; McElroy SL; Arnold LM
Expert Opin Pharmacother; 2001 Jun; 2(6):1033-42. PubMed ID: 11585006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
